Detalhe da pesquisa
1.
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1ß, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy.
Circulation
; 146(5): 372-379, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762321
2.
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Circulation
; 144(22): 1750-1759, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706555
3.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Circulation
; 144(23): 1845-1855, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710343
4.
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Circulation
; 143(1): 33-44, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148016
5.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
N Engl J Med
; 380(1): 11-22, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415628
6.
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
Circulation
; 141(5): 367-375, 2020 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707829
7.
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies.
Eur Heart J Suppl
; 22(Suppl J): J34-J48, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33061866
8.
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
Eur Heart J
; 45(13): 1173-1176, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252107
9.
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
JAMA
; 315(5): 469-79, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26836729
10.
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN).
Ann Rheum Dis
; 74(6): 1051-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550171
11.
Missing radiographic data handling in randomized clinical trials in rheumatoid arthritis.
J Biopharm Stat
; 23(6): 1435-52, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24138441
12.
Comparing the effects of three processing methods on the efficacy of mulberry leaf tea: Analysis of bioactive compounds, bioavailability and bioactivity.
Food Chem
; 405(Pt B): 134900, 2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413845
13.
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking.
Eur Heart J Cardiovasc Pharmacother
; 9(2): 129-137, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953437
14.
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.
J Am Heart Assoc
; 12(5): e026756, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802845
15.
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.
J Am Heart Assoc
; 11(7): e024999, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377160
16.
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl.
Am J Prev Cardiol
; 10: 100345, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574517
17.
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
J Am Coll Cardiol
; 79(17): 1660-1671, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483753
18.
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
J Am Heart Assoc
; 11(6): e022937, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261279
19.
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
J Am Coll Cardiol
; 78(15): 1525-1537, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620410
20.
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19.
iScience
; 24(9): 103040, 2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462732